Disease Overview：Testicular Tumor（TT）
Testicular tumors are rare but highly treatable malignancies arising from germ cells or stromal tissues of the testes, predominantly affecting men aged 15–45. The most common histological subtypes include seminoma and non-seminomatous germ cell tumors (NSGCT), such as embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratoma. Early diagnosis—often prompted by painless testicular swelling, heaviness, or a palpable mass—is critical, as these tumors demonstrate exceptional sensitivity to cisplatin-based chemotherapy and radiation therapy (especially for stage I seminoma). Staging relies on high-resolution scrotal ultrasound, serum tumor markers (AFP, β-hCG, LDH), and contrast-enhanced CT/MRI of abdomen and chest. With timely intervention, five-year survival exceeds 95% for localized disease and remains above 80% even in metastatic settings.
China offers distinct advantages in managing testicular tumors: leading uro-oncology centers—such as Peking University First Hospital and Fudan University Shanghai Cancer Center—maintain multidisciplinary tumor boards with internationally trained specialists, utilize state-of-the-art PET-CT, robotic-assisted retroperitoneal lymph node dissection (RPLND), and precision oncology platforms for biomarker-guided therapy. Clinical outcomes align with global benchmarks: over 92% five-year survival for stage II/III disease is routinely reported across Tier-1 institutions. Treatment costs in China average 40–60% lower than in the US or Western Europe, without compromising protocol adherence or surveillance standards. As a dedicated medical tourism agency, we facilitate seamless access for international patients—handling hospital referrals, coordinating pre-arrival diagnostics, ensuring transparent all-inclusive pricing, arranging visa support, and providing bilingual clinical liaison and post-treatment follow-up coordination.
Testicular Tumor: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Testicular Tumors (Urology)
Non-Surgical / Conservative / Medical Management
*Indicated for Stage I seminoma surveillance, low-risk germ cell tumor adjuvant therapy, or palliative care in metastatic disease.*
- •Active Surveillance (Stage I Seminoma)
- *Annual Costs (USD)*: • Physical exam + scrotal ultrasound: $85 • Chest X-ray + abdominal/pelvic CT: $240 • Serum tumor markers (AFP, β-hCG, LDH): $45 • Total Year 1: $370; Years 2–5: $290/year
- •Adjuvant Carboplatin (Single Cycle)
- *Costs (USD)*: • Pre-chemo labs (CBC, renal/hepatic panel, electrolytes): $35 • Carboplatin infusion (AUC 7, 1 dose): $180 • Day-care nursing + monitoring: $65 • Total per cycle: $280
Surgical / Procedural Options
*All procedures performed by urologic oncology teams in Grade 3A hospitals.*
- •Radical Inguinal Orchiectomy
- *Pre-op Workup (USD)*: • Scrotal ultrasound: $65 • CT chest/abdomen/pelvis: $240 • Tumor markers (AFP, β-hCG, LDH): $45 - *Procedure Cost (USD)*: • Standard open or laparoscopic approach: $1,420–$1,850 (varies by anesthesia type, hospital tier, length of stay)
- •Retroperitoneal Lymph Node Dissection (RPLND)
- *Pre-op Workup (USD)*: Same as above ($350) - *Procedure Cost (USD)*: • Open RPLND: $3,200–$4,100 • Robotic-assisted RPLND: $4,800–$5,900
Special / Complex Condition Management
- •Metastatic Germ Cell Tumor (Stage III)
• Salvage high-dose chemotherapy + autologous stem cell transplant: $14,200–$17,600 (includes mobilization, apheresis, conditioning, transplant, 14-day inpatient care)
Quick Selection Guide
- •Young adult (<35), low-stage, budget-conscious: Radical orchiectomy + active surveillance ($1,790 total Year 1)
- •Middle-aged (35–55), comorbidities (e.g., CKD, COPD): Adjuvant carboplatin over RPLND to avoid major surgery ($315 total)
- •High-risk Stage II non-seminoma, fit patient: Open RPLND ($3,550 total) — superior long-term cure vs. chemo alone
- •Metastatic disease with poor prognosis: BEP × 4 cycles ($4,600 total) — standard first-line; avoid robotic RPLND due to unresectable burden
- •Elderly (>70) with multiple comorbidities and small-volume disease: Palliative orchiectomy only ($1,420) + best supportive care
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Testicular Tumor Medical Vacation Packages
Curated transparent all-inclusive packages combining Testicular Tumor treatment with China top medical destinations:
